Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Self-reported measures of antiretroviral adherence vary greatly in recall time periods and response tasks. To determine which time frame is most accurate, we compared 3-, 7-day, and 1-month self-reports with data from medication event monitoring system (MEMS). To determine which response task is most accurate we compared three different 1-month self-report tasks (frequency, percent, and rating) to MEMS. We analyzed 643 study visits made by 156 participants. Over-reporting (self-report minus MEMS) was significantly less for the 1-month recall period (9%) than for the 3 (17%) or 7-day (14%) periods. Over-reporting was significantly less for the 1-month rating task (3%) than for the 1-month frequency and percent tasks (both 12%). We conclude that 1-month recall periods may be more accurate than 3- or 7-day periods, and that items that ask respondents to rate their adherence may be more accurate than those that ask about frequencies or percents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a 5-item scale that has been shown sensitive to variations in health states related to HIV, mental health,53,54 and tobacco use.55,56”
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · cited 2×
“We use the Medical Outcome Study 12-item short-form health survey to assess physical and mental health (Ware et al. 1996), and the PC-SAD to assess depression (Rogers et al. 2002).”
MethodPalella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405 · cited 1×
“Highly active antiretroviral therapy (HAART) has led to a dramatic decline in human immunodeficiency virus (HIV) mortality and morbidity (Hogg et al. 1998; Palella et al. 1998).”
BackgroundAdherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289 · cited 1×
“Both clinical trials and cohort studies have shown that adherence to antiretroviral (ARV) medication is one of the most important factors for the success of HAART (Arnsten et al. 2001; Bangsberg et al. 2001; Chesney et al.1999; Paterson et al. 2000).”
BackgroundPreston, C. C., & Colman, A. M. (2000) · Acta Psychologica · doi:10.1016/s0001-6918(99)00050-5 · Cited by 2,106 · cited 2×
“For analysis we assigned the six categories scores of 0, 20, 40, 60, 80, and 100, with 100 being the best adherence ( Preston and Colman 2000 ).”
MethodChesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE (2000) · AIDS Care · doi:10.1080/09540120050042891 · Cited by 1,428 · cited 1×
“The widely used Aids Clinical Trials Group (ACTG) adherence instruments employs a 4-day recall period (Chesney et al. 2000).”
MethodPeters, E., Västfjäll, D., Slovic, P., Mertz, C. K., Mazzocco, K., & Dickert, S. (2006) · Psychological Science · doi:10.1111/j.1467-9280.2006.01720.x · Cited by 1,180
The Role of Numeracy in Understanding the Benefit of Screening Mammography
Schwartz, L. M., Woloshin, S., Black, W. C., & Welch, H. G. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00003 · Cited by 1,130 · cited 1×
“Recognition of health numeracy as an issue for patient self-management and participatory decision-making is growing (Apter et al. 2006; Gazmararian et al. 1999; Montori and Rothman 2005; Peters et al. 2006; Schwartz et al. 1997; Woloshin et al. 2005).”
BackgroundBangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033 · cited 1×
“Poor adherence is associated with treatment failure, resistance, and the transmission of resistant viruses (Bangsberg et al. 2000; Vanhove et al.1996).”
Background
Research works printed but not linked: 2
- Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Suppl A), S271–S278.
- Montori, V. M., Leung, T. W., Thompson, C. A., Chung, J. A., Capes, S. E., & Smith, S. A. (2004). Choice of risk representation to enable diabetes decision-making. Diabetes, 53(Suppl 2), A225.
Cited by
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesis
Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.3.18640 · Cited by 1,126
“response measure [126] and a 30-day VAS”
Self-report measures of medication adherence behavior: recommendations on optimal use
Stirratt, M. J., Dunbar-Jacob, J., Crane, H. M., Simoni, J. M., Czajkowski, S., Hilliard, M. E., Aikens, J. E., Hunter, C. M., Velligan, D. I., Huntley, K., et al. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0315-2 · Cited by 824
“Studies comparing self-report measures with different recall time frames have determined that 30-day recall intervals reduce ceiling effects relative to shorter intervals [44, 68, 69, 71].”
BackgroundLiu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
“The incidence (95% CI) of STIs per 100 person-years was 48 (42-55) for C trachomatis, 43 (37-49) for N gonorrhoeae, 12 (9-16) for syphilis, and 90 (81-99) for any STI; in each case, the incidence was stable across quarterly intervals (all, P > .”
BackgroundTuran, B., Budhwani, H., Fazeli, P. L., Browning, W. R., Raper, J. L., Mugavero, M. J., & Turan, J. M. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1451-5 · Cited by 480
“[32]: ‘‘In the past 4 weeks, how was your ability to take all of your anti-HIV medications that were prescribed by your doctor?’’ (reported in a recent manuscript [9]).”
BackgroundSweeney, S. M., & Vanable, P. A. (2016) · AIDS and Behavior · doi:10.1007/s10461-015-1164-1 · Cited by 350
“One study has compared multiple recall periods and response formats for self-report adherence measures with electronic monitoring device data [90].”
BackgroundDefining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
Haberer, J. E., Bangsberg, D. R., Baeten, J. M., Curran, K., Koechlin, F., Amico, K. R., Anderson, P., Mugo, N., Venter, F., Goicochea, P., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000647 · Cited by 319
“Accuracy, however, may increase via short recall periods [23,24] and concurrent measurement with medication adherence (e.”
BackgroundAssessing medication adherence: options to consider
Lehmann, A., Aslani, P., Ahmed, R., Celio, J., Gauchet, A., Bedouch, P., Bugnon, O., Allenet, B., & Schneider, M. P. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9865-x · Cited by 318
“The retrieved full texts were classified within a table according to the measure of adherence used (see ‘‘Appendix’’ [1, 6, 12–113]).”
BackgroundMethodGarfield, S., Clifford, S., Eliasson, L., Barber, N., & Willson, A. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-149 · Cited by 286
“Studies that report development, reliability or validation of a retrospective self report adherence measure against a non-questionnaire measure (such as MEMS, pill counts and clinical markers).”
BackgroundResultInfluentialAdherence to Antiretroviral Therapy Among HIV-Infected Drug Users: A Meta-Analysis
Malta, M., Magnanini, M. M. F., Strathdee, S. A., & Bastos, F. I. (2010) · AIDS and Behavior · doi:10.1007/s10461-008-9489-7 · Cited by 225
Mimiaga, M. J., Reisner, S. L., Grasso, C., Crane, H. M., Safren, S. A., Kitahata, M. M., Schumacher, J. E., Mathews, W. C., & Mayer, K. H. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301162 · Cited by 224
Self-citationAdherence to Cardiovascular Medications: Lessons Learned and Future Directions
Kronish, I. M., & Ye, S. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.02.001 · Cited by 213
A Proposal for Quality Standards for Measuring Medication Adherence in Research
Williams, A. B., Amico, K. R., Bova, C., & Womack, J. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-012-0172-7 · Cited by 198
“Adherence Index Questionnaire [29], or general ability ratings [30].”
InfluentialEl Alili, M., Vrijens, B., Demonceau, J., Evers, S. M., & Hiligsmann, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12942 · Cited by 195
A Structural Equation Model of HIV-Related Stigma, Depressive Symptoms, and Medication Adherence
Rao, D., Feldman, B. J., Fredericksen, R. J., Crane, P. K., Simoni, J. M., Kitahata, M. M., & Crane, H. M. (2012) · AIDS and Behavior · doi:10.1007/s10461-011-9915-0 · Cited by 194
“Finally, patients were asked to rate their HIV medication adherence over the past month on a visual analog scale that ranged from 0 to 100% [24, 25].”
Distress and type 2 diabetes-treatment adherence: A mediating role for perceived control.
Gonzalez, J. S., Shreck, E., Psaros, C., & Safren, S. A. (2015) · Health Psychology · doi:10.1037/hea0000131 · Cited by 191
Self-citationShi, L., Liu, J., Koleva, Y., Fonseca, V., Kalsekar, A., & Pawaskar, M. (2010) · PharmacoEconomics · doi:10.2165/11537400-000000000-00000 · Cited by 189
“,([43]) 2008, USA MEMS Unnamed n= 156, 42, HIV 69.”
BackgroundInfluentialDang, B. N., Westbrook, R. A., Black, W. C., Rodriguez-Barradas, M. C., & Giordano, T. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054729 · Cited by 184
“In the past 4 weeks, how would you rate your ability to take all your HIV medicines as your doctor prescribed?’’ The 6-point response scale ranged from ‘‘very poor’’ to ‘‘excellent’’ [15,16].”
MethodShi, L., Liu, J., Fonseca, V., Walker, P., Kalsekar, A., & Pawaskar, M. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-99 · Cited by 177
“Across 11 articles finally included in the meta-analysis [16-26], 7 (63.”
BackgroundFeldman, B. J., Fredericksen, R. J., Crane, P. K., Safren, S. A., Mugavero, M. J., Willig, J. H., Simoni, J. M., Wilson, I. B., Saag, M. S., Kitahata, M. M., et al. (2013) · AIDS and Behavior · doi:10.1007/s10461-012-0326-7 · Cited by 159
“seemed to fare best in that it yielded less over-reporting of adherence than other self-report measures [39].”
BackgroundMethodResultInfluentialSelf-citationEffectiveness of Collaborative Care for Depression in Human Immunodeficiency Virus Clinics
Pyne, J. M., Fortney, J. C., Curran, G. M., Tripathi, S., Atkinson, J. H., Kilbourne, A. M., Hagedorn, H. J., Rimland, D., Rodriguez-Barradas, M. C., Monson, T., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.395 · Cited by 132
“We may have failed to detect medication prescription or adherence effects because of self-report measurement error.(64,65) The intervention may have led to greater dose intensification or treatment switching not detected by our measurement methods.”
Friedman, M. R., Coulter, R. W. S., Silvestre, A. J., Stall, R. D., Teplin, L. A., SHOPTAW, S. J., Surkan, P. J., & Plankey, M. W. (2016) · AIDS Care · doi:10.1080/09540121.2016.1211614 · Cited by 135
“between social support and adherence (Lu et al., 2008).”
Helms, C. B., Turan, J. M., Atkins, G. C., Kempf, M.-C., Clay, O. J., Raper, J. L., Mugavero, M. J., & Turan, B. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1320-2 · Cited by 140
“Previous research suggests that this single item scale is a valid measure of adherence [45, 46].”
Cognitive and Field Testing of a New Set of Medication Adherence Self-Report Items for HIV Care
Wilson, I. B., Fowler, F. J., Cosenza, C. A., Michaud, J., Bentkover, J., Rana, A., Kogelman, L., & Rogers, W. H. (2014) · AIDS and Behavior · doi:10.1007/s10461-013-0610-1 · Cited by 117
“Interestingly, the rating item that we tested previously [16] was worded as follows: ‘‘Thinking back over the last month, on average how would you rate your ability to take all your [HIV] medications as prescribed.”
BackgroundResultSelf-citationBlackstone, K., Moore, D. J., Heaton, R. K., Franklin, D. R., Woods, S. P., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., et al. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s135561771100141x · Cited by 117
“For example, a recent study that examined self-report versus electronic medication monitoring of antiretroviral medications found that self-report significantly overestimated adherence rates (self-report up to 90% adherent vs. electronic monitoring 70% adherent; Lu et al., 2008).”
ResultAssociation Between Internalized HIV-Related Stigma and HIV Care Visit Adherence
Rice, W. S., Crockett, K. B., Mugavero, M. J., Raper, J. L., Atkins, G. C., & Turan, B. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001543 · Cited by 115
Turan, B., Rice, W. S., Crockett, K. B., Johnson, M. O., Neilands, T. B., Ross, S. N., Kempf, M.-C., Konkle‐Parker, D. J., Wingood, G. M., Tien, P. C., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002071 · Cited by 131
“dichotomized the measure at 95% or higher versus lower than 95% [20,21].”
Kwan, Y. H., Weng, S. D., Loh, D. H. F., Phang, J. K., Oo, L. J. Y., Blalock, D. V., Chew, E., Yap, K. Z., Tan, C. Y. K., Yoon, S., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/19179 · Cited by 136
Haberer, J. E., Cook, A. D., Walker, A. S., Ngambi, M., Ferrier, A., Mulenga, V., Kityo, C. M., Thomason, M. J., Kabamba, D., Chintu, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018505 · Cited by 115
“Caregiver-report of last missed ART dose had a relatively high agreement with MEMS.”
BackgroundInfluentialSprich, S. E., Safren, S. A., Finkelstein, D., Remmert, J. E., & Hammerness, P. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12549 · Cited by 114
Self-citationIdentifying the barriers to antiepileptic drug adherence among adults with epilepsy
Rourke, G. O., & Brien, J. J. O. (2016) · Seizure · doi:10.1016/j.seizure.2016.12.006 · Cited by 127
Thrasher, A. D., Earp, J. A., Golin, C. E., & Zimmer, C. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181845589 · Cited by 113
Patient Activation and Improved Outcomes in HIV-Infected Patients
Marshall, R., Beach, M. C., Saha, S. S., Mori, T., Loveless, M. O., Hibbard, J. H., Cohn, J. A., Sharp, V., & Korthuis, P. T. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2307-y · Cited by 130
“lesser adherence in precipitating antiretroviral resistance.(24) Clinical outcome variables included CD4 cell count>200 cells/mL(3) and HIV1 RNA<400 copies/mL (viral suppression) abstracted from medical records.”
BackgroundDuncan, L. G., Moskowitz, J. T., Neilands, T. B., Dilworth, S. E., Hecht, F. M., & Johnson, M. O. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.04.007 · Cited by 110
“The 30-day time frame also has empirical support.(33) For the present study, the mean percent adherence was calculated across all drugs in the participant’s ART regimen.”
Primary Relationships, HIV Treatment Adherence, and Virologic Control
Johnson, M. O., Dilworth, S. E., Taylor, J. M., Darbes, L. A., Comfort, M. L., & Neilands, T. B. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-0021-0 · Cited by 115
“’’ This measure has shown to be correlated with other adherence measures such as electronic medication monitors [58, 59], and a 30-day timeframe has recently been supported as preferable to other approaches of self report [60].”
Validity of Medication Adherence Self-Reports in Adults With Type 2 Diabetes
Gonzalez, J. S., Schneider, H. E., Wexler, D. J., Psaros, C., Delahanty, L. M., Cagliero, E., & Safren, S. A. (2013) · Diabetes Care · doi:10.2337/dc12-0410 · Cited by 104
“The recalled time frame of these measures also related to concordance: 1-month recall periods were more accurate than 3- and 7-day recall periods (12).”
BackgroundResultInfluentialSelf-citationTurner, B. J., Hollenbeak, C., Weiner, M. G., Ten Have, T., & Roberts, C. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1766 · Cited by 103
“In HIV-infected patients, Lu et al.(34) reported that selfreported adherence was most predictive of viral load when based on a longer 1-month window than the usual one week or shorter interval.”
Kay, E. S., Rice, W. S., Crockett, K. B., Atkins, G. C., Batey, D. S., & Turan, B. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001590 · Cited by 107
Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults
Fredericksen, R. (2012) · Journal of AIDS and HIV Research · doi:10.5897/jahr11.046 · Cited by 100
“, 2000), a rating scale item (Lu et al., 2008), and a visual analogue scale item (Giordano et al.”
Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence
Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., Grant, I., & the HNRC Group (2012) · AIDS Care · doi:10.1080/09540121.2012.672718 · Cited by 101
“Additionally, our study is limited by the use of self-reported medication adherence evaluation, which may underestimate actual adherence difficulties (Lu et al., 2008); however, any endorsement of non-adherence is likely to be valid (Arnsten et al., 2001; Levine et al., 2006).”
MethodClifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99
“, the approach taken by Lu et al.(72) in a methodological paper regarding assessment of medication adherence in patients with HIV.”
MethodMeade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9293-5 · Cited by 111
“In all cases, a 1-month recall period was used because it has been found to be more strongly associated with objective measures of adherence than 3- or 7-day periods (Lu et al. 2008).”
BackgroundMethodInfluentialSelf-citationNewman, P. M., Franke, M. F., Arrieta, J., Carrasco, H., Elliott, P. F., Flores, H., Friedman, A. K., Graham, S., Martínez‐Juárez, L. A., Palazuelos, L., et al. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2017-000566 · Cited by 93
“Controlled diabetes and/or hypertension 41 (38) 18 (42) 6 (25) 15 (60) 2 (13)”
Turan, B., Rogers, A. J., Rice, W. S., Atkins, G. C., Cohen, M. H., Wilson, T. E., Adimora, A. A., Merenstein, D., Adedimeji, A., Wentz, E. L., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1957-5 · Cited by 88
“This measure has been shown to be a valid measure of adherence [42, 43].”
Investigating Partner Abuse Among HIV-Positive Men Who have Sex with Men
Pantalone, D. W., Schneider, K. L., Valentine, S. E., & Simoni, J. M. (2012) · AIDS and Behavior · doi:10.1007/s10461-011-0011-2 · Cited by 86
“Based on evidence indicating that a ‘‘past 30 days’’ timeframe for a self-report measure may more accurately reflect true adherence [61], here we report the proportion of the sample that endorsed 100% ARV adherence during that timeframe.”
Haberer, J. E., Robbins, G. K., Ybarra, M., Monk, A., Ragland, K., Weiser, S. D., Johnson, M. O., & Bangsberg, D. R. (2012) · AIDS and Behavior · doi:10.1007/s10461-011-9933-y · Cited by 83
“Patient interview is imprecise [5], pharmacy refill reflects maximum possible adherence [6], unannounced pill counts are expensive and labor-intensive [2], and electronic monitoring precludes the use of pill box organizers, which are effective, simple, and inexpensive adherence support tools [7].”
Wilson, I. B., Carter, A. E., & Berg, K. M. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0024-x · Cited by 83
Self-citationAntiretroviral Concentrations in Small Hair Samples as a Feasible Marker of Adherence in Rural Kenya
Hickey, M. D., Salmen, C. R., Tessler, R. A., Omollo, D. O., Bacchetti, P., Magerenge, R., Mattah, B. J., Salmen, M. R., Zoughbie, D. E., Fiorella, K. J., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000154 · Cited by 83
Gonzalez, J. S., Kane, N. S., Binko, D. H., Shapira, A., & Hoogendoorn, C. J. (2016) · Diabetes Care · doi:10.2337/dc16-1657 · Cited by 80
“(28) and were previously validated in adults with type 2 diabetes (29).”
BackgroundAdherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
Montgomery, M. C., Oldenburg, C. E., Nunn, A. S., Mena, L. A., Anderson, P. L., Liegler, T. J., Mayer, K. H., Patel, R. R., Almonte, A. A., & Chan, P. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157742 · Cited by 82
“Recall over seven- and 30-day periods is commonly used as a measure of adherence, and these measures have demonstrated reliability when compared to objective measures of adherence [17].”
MethodCorrelates of antiretroviral adherence and viral load among transgender women living with HIV
Sevelius, J. M., Saberi, P., & Johnson, M. O. (2014) · AIDS Care · doi:10.1080/09540121.2014.896451 · Cited by 83
“HIV clinical outcomes—ART adherence over the previous 30 days was assessed using a single rating item, which in previous research produced adherence reports most closely associated with medication electronic event monitors (Lu et al., 2008): “Rate your ability to take all your medications as prescribed” with six respo…”
MethodNakhutina, L., Gonzalez, J. S., Margolis, S. A., Spada, A. H., & Grant, A. C. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.08.007 · Cited by 77
“For example, both treatment-specific beliefs and beliefs about medications in general predicted adherence to antiretroviral medication over time in a sample of patients with HIV/AIDS.”
MethodInfluentialBuscher, A. L., Hartman, C. M., Kallen, M. A., & Giordano, T. P. (2011) · HIV Clinical Trials · doi:10.1310/hct1205-244 · Cited by 70
Johnson, M. O., Dilworth, S. E., Taylor, J. M., & Neilands, T. B. (2011) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9230-4 · Cited by 69
“” This measure has shown to be correlated with other measures of adherence, such as medication event monitoring systems [35, 36] and a 30-day timeframe has recently been supported as preferable to other approaches of self-report [37].”
ResultUsitalo, A., Leister, E. C., Tassiopoulos, K., Allison, S. M., Malee, K., Paul, M. E., Smith, R. A., Dyke, R. B. V., Seage, G. R., & Mellins, C. A. (2013) · AIDS Care · doi:10.1080/09540121.2013.802280 · Cited by 69
“…using visual analog scales or percentages; or (3) use multi-item rating scales have demonstrated association with VL across multiple studies (Deschamps et al., 2008; Doró et al., 2011; Farley et al., 2008; Kalichman et al., 2009; Lu et al., 2008; Munoz-Moreno et al., 2007; Simoni et al., 2006).”
MethodChotiyaputta, W., Hongthanakorn, C., Oberhelman, K., Fontana, R. J., Licari, T. L., & Lok, A. S.-F. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01494.x · Cited by 69
Saberi, P., Siedle-Khan, R., Sheon, N. M., & Lightfoot, M. A. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0044 · Cited by 73
“8%) based on the ART adherence rating scale.(23) The most commonly reported reason for nonadherence were sleeping through dosing time (52.”
MethodYiğit, İ., Bayramoglu, Y., Weiser, S. D., Johnson, M. O., Mugavero, M. J., Turan, J. M., & Turan, B. (2020) · AIDS Patient Care and STDs · doi:10.1089/apc.2020.0114 · Cited by 76
“ART adherence was assessed with the single question, 36 ‘‘Thinking about the past 4 weeks, on average how would you rate your ability to take all of your HIV antiretroviral medications as your doctor prescribed’’ with response options ranging from very poor to excellent.”
Biello, K. B., Marrow, E., Mimiaga, M. J., Sullivan, P. S., Hightow‐Weidman, L., & Mayer, K. H. (2018) · JMIR Research Protocols · doi:10.2196/10694 · Cited by 68
“HIV or STI testing history, PrEP awareness, barriers to PrEP uptake, PrEP adherence [50], barriers to PrEP use HIV Negative Cascade”
BackgroundNokes, K. M., Johnson, M. O., Webel, A. R., Rose, C. D., Phillips, J. C., Sullivan, K. M., Tyer‐Viola, L. A., Rivero‐Méndez, M., Nicholas, P. K., Kemppainen, J. K., et al. (2012) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2012.01476.x · Cited by 77
Grierson, J., Koelmeyer, R., Smith, A., & Pitts, M. (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00928.x · Cited by 63
Musinguzi, N., Muganzi, C. D., Boum, Y., Ronald, A., Marzinke, M. A., Hendrix, C. W., Celum, C., Baeten, J. M., Bangsberg, D. R., & Haberer, J. E. (2016) · AIDS · doi:10.1097/qad.0000000000001024 · Cited by 67
“As has been done previously [21], self-reported rating and self-reported frequency response categories were assigned quantitative adherence in 20% increments.”
MethodCuca, Y. P., Shumway, M., Machtinger, E. L., Davis, K., Khanna, N., Cocohoba, J. M., & Dawson-Rose, C. S. (2019) · Women s Health Issues · doi:10.1016/j.whi.2019.06.001 · Cited by 69
“on a validated six-point scale (Lu et al., 2008), dichotomized into good 30day adherence (good, very good, or excellent) or not (very poor, poor, or fair).”
BackgroundMethodMobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial
Gerber, B. S., Biggers, A., Tilton, J. J., Smith Marsh, D. E., Lane, R., Mihailescu, D., Lee, J., & Sharp, L. K. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.33629 · Cited by 61
Venkatesh, K. K., Srikrishnan, A. K., Mayer, K. H., Kumarasamy, N., Raminani, S. R., Thamburaj, E., Prasad, L., Triche, E. W., Solomon, S., & Safren, S. A. (2010) · AIDS Patient Care and STDs · doi:10.1089/apc.2010.0153 · Cited by 66
“The outcome of HAART adherence during the past month was calculated based on dividing percentages from the 30-day visual analogue scale.(32) Because this variable was highly skewed, we dichotomized adherence, coding participants achieving less than 95% adherence as ‘‘1’’ and those 95% or more adherence as ‘‘0.”
Self-citationAdvances in the Science of Asking Questions
Schaeffer, N. C., & Dykema, J. (2020) · Annual Review of Sociology · doi:10.1146/annurev-soc-121919-054544 · Cited by 66
“Some topics we do not cover because research is still accumulating, for example, are specifications such as reference periods (Lu et al. 2008) and parentheses (Dykema et al. 2016); or because the topics are specialized, such as visual analogue scales (Couper et al. 2006), event-history calendars…”
BackgroundKurth, A., Spielberg, F., Cleland, C. M., Lambdin, B. H., Bangsberg, D. R., Frick, P. A., Severynen, A. O., Clausen, M., Norman, R. G., Lockhart, D., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000100 · Cited by 64
“Common plans for ART adherence were to ‘keep doing what I am doing’ (n = 32) ‘use reminders’ (31), and ‘get support’ (25).”
Beach, M. C., ROTER, D. L., Saha, S. S., Korthuis, P. T., Eggly, S. S., Cohn, J. A., Sharp, V., Moore, R. D., & Wilson, I. B. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2015.05.011 · Cited by 65
“In post-visit interviews, patients were asked to rate their overall satisfaction with care and also self-reported additional sociodemographic information such as age, sex, education, overall adherence to medications (using a previously-validated single item question, “How would you rate your adherence to your antiHIV…”
MethodSelf-citationJneid, S., Jabbour, K., Hajj, A., Sarkis, A., Licha, H., Hallit, S. R., & Khabbaz, L. R. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418784292 · Cited by 83
Lipira, L. E., Williams, E. C., Huh, D., Kemp, C. G., Nevin, P. E., Greene, P. A., Unger, J. M., Heagerty, P. J., French, A. L., Cohn, S. E., et al. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2301-4 · Cited by 57
Buffering Internalization of HIV Stigma: Implications for Treatment Adherence and Depression
Turan, B., Crockett, K. B., Büyükcan-Tetik, A., Kempf, M.-C., Konkle‐Parker, D. J., Wilson, T. E., Tien, P. C., Wingood, G. M., Neilands, T. B., Johnson, M. O., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001915 · Cited by 61
Wilson, I. B., Laws, M. B., Safren, S. A., Lee, Y., Lu, M., Coady, W., Skolnik, P. R., & Rogers, W. H. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c7a245 · Cited by 55
“For self-reported adherence, we used a rating item shown in previous analyses to be most associated with MEMS.27 Patients were asked, ‘‘rate your ability to take all your medications as prescribed’’ (6 categories: very poor, poor, fair, good, very good, and excellent).”
MethodSelf-citationAdherence of Subjects With Cystic Fibrosis to Their Home Program: A Systematic Review
O'Donohoe, R., & Fullen, B. M. (2014) · Respiratory Care · doi:10.4187/respcare.02990 · Cited by 64
Comparison of Antiretroviral Adherence Questions
Berg, K. M., Wilson, I. B., Li, X., & Arnsten, J. H. (2012) · AIDS and Behavior · doi:10.1007/s10461-010-9864-z · Cited by 54
“currently used electronic pill bottle monitors [16].”
Self-citationSalgado, T. M., Mackler, E. R., Severson, J. A., Lindsay, J., Batra, P., Petersen, L., & Farris, K. B. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3584-0 · Cited by 53
“[29] demonstrated that self-reporting excellent adherence corresponded to a mean of about 80% adherence when compared to bottle opening using medication event moni tor ing sys tem (MEMS).”
ResultChakraborty, A., Hershow, R. C., Qato, D. M., Stayner, L. T., & Dworkin, M. S. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02779-4 · Cited by 57
Methodological Issues in the Assessment of Diabetes Treatment Adherence
Gonzalez, J. S., & Schneider, H. E. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0229-4 · Cited by 59
Baker, Z. G., Javanbakht, M., Mierzwa, S., Pavel, C., Lally, M., Zimet, G. D., & Gorbach, P. M. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1958-4 · Cited by 54
“Thirty day recall, however, has previously been demonstrated as having lower rates of over-reporting of HIV medication adherence, as compared with three day or seven day recall [29].”
van der Straten, A., Brown, E. R., Marrazzo, J. M., Chirenje, M., Liu, K., Gomez, K., Marzinke, M. A., Piper, J. M., Hendrix, C. W., & on behalf of the MTN‐003 VOICE Protocol Team for the Microbicide Trials Network (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20642 · Cited by 52
“During the ACASI, participants were also asked to rate their ability to use the product as instructed in the previous 4 weeks, using a validated six-point rating scale (very low to excellent) [29].”
Seghatol-Eslami, V. C., Dark, H. E., Raper, J. L., Mugavero, M. J., Turan, J. M., & Turan, B. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001177 · Cited by 51
Wright, I., Reid, R., Shahid, N. N., Ponce, A., Nelson, C. M., Sanders, J., Gardner, N., Liu, J., Simmons, E. M., Phillips, A., et al. (2022) · American Journal of Public Health · doi:10.2105/ajph.2021.306675 · Cited by 54
Self-citationTelephone Nurse Counseling Improves HIV Medication Adherence: An Effectiveness Study
Cook, P. F., McCabe, M. M., Emiliozzi, S., & Pointer, L. (2009) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2009.02.008 · Cited by 47
“Participants’ ART adherence was recorded by the ScriptAssist nurse at the time of each telephone call based on the participant’s response to the question ‘‘What percentage of the time do you currently take your medication as prescribed?’’ When adherence is assessed in a nonjudgmental interview format by someone other…”
BackgroundMethodStirratt, M. J., & Gordon, C. M. (2008) · Current HIV/AIDS Reports · doi:10.1007/s11904-008-0027-z · Cited by 49
“With the development of simplifi ed regimens, incorporating longer assessment intervals of 7 days [19•] or even 30 days [ 22 ] may better capture potentially infrequent instances of nonadherence.”
BackgroundSidorkiewicz, S., Tran, V.-T., Cousyn, C., Perrodeau, É., & Ravaud, P. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010510 · Cited by 53
“We hypothesised that this approach would be easier for patients than asking them for an accurate number of doses missed.(14) For example, we considered that a patient usually missing a single dose every month would have had difficulties choosing”
BackgroundPsaros, C., Smit, J. A., Mosery, N., Bennett, K. K., Coleman, J. N., Bangsberg, D. R., & Safren, S. A. (2020) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa005 · Cited by 53
“[52] and consisted of four questions that comprised different response formats, including frequency, percent, and rating responses.”
BackgroundMethodSelf-citationShreck, E., Gonzalez, J. S., Cohen, H. W., & Walker, E. A. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9291-4 · Cited by 50
“Nevertheless, single-item measures of self-reported medication adherence do have strong evidence for validity, both in the literature on HIV/AIDS medication adherence and in adults with type 2 diabetes [53, 54].”
Dale, S. K. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00715-9 · Cited by 46
Treatment adherence and transitioning youth in pediatric multiple sclerosis
Lulu, S., Julian, L. J., Shapiro, E. M., Hudson, K., & Waubant, E. L. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.09.088 · Cited by 46
“We selected a one month time period to avoid recall bias (Lu et al. 2008, 86–94).”
BackgroundMethodTuran, B., Fazeli, P. L., Raper, J. L., Mugavero, M. J., & Johnson, M. O. (2016) · Health Psychology · doi:10.1037/hea0000356 · Cited by 51
“Previous research suggests that this single item is a valid measure of ART adherence (Feldman et al., 2013; Lu et al., 2008).”
BackgroundChung, W. W., Chua, S. S., Lai, P. S. M., & Morisky, D. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124275 · Cited by 49
“Lu et al demonstrated that self-reported medication adherence was dependent on the recall period and a one-month duration was deemed practical [36].”
BackgroundBody image disturbance and health behaviors among sexual minority men living with HIV.
Blashill, A. J., Goshe, B. M., Robbins, G. K., Mayer, K. H., & Safren, S. A. (2014) · Health Psychology · doi:10.1037/hea0000081 · Cited by 45
“” This item has been shown to be a valid indicator of ART adherence (Feldman et al., 2013; Lu et al., 2008).”
BackgroundSelf-citationImportance of Dose Timing to Achieving Undetectable Viral Loads
Gill, C. J., Sabin, L., Hamer, D. H., Xu, K., Jianbo, Z., Li, T., Wu, W., Wilson, I. B., & DeSilva, M. B. (2009) · AIDS and Behavior · doi:10.1007/s10461-009-9555-9 · Cited by 44
Self-citationParry, C. D., Morojele, N. K., Myers, B. J., Kekwaletswe, C. T., Manda, S. O., Sorsdahl, K., Ramjee, G., Hahn, J. A., Rehm, J., & Shuper, P. A. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-500 · Cited by 43
“For the ACTG and VAS, adherence levels will be examined in terms of both continuous and dichotomous measures (e.g. cut-offs of 90%, 95%, and 100% adherence rates); (3) The CASE Adherence Index [52]; and (4) The Self-Rating Scale Item (SRSI) [53,54].”
Li, J., Si, Y., Hu, J., Liu, L., Deng, Y., He, J., Zhang, N., & Zhou, D. (2013) · Epilepsia · doi:10.1111/epi.12382 · Cited by 44
“Six response options were available (Lu et al., 2008).”
Graham, S. M., Micheni, M., Chirro, O., Nzioka, J., Secor, A., Mugo, P. M., Kombo, B. K., van der Elst, E., Operario, D., Amico, K. R., et al. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02786-5 · Cited by 44
A longitudinal investigation of the impact of life stress on HIV treatment adherence
Bottonari, K. A., Safren, S. A., McQuaid, J. R., Hsiao, C. B., & Roberts, J. E. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9273-9 · Cited by 53
Self-citationHalepian, L., Saleh, M. B., Hallit, S. R., & Khabbaz, L. R. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0389-1 · Cited by 48
“’s questionnaire [24] by asking the patients about the frequency, percentage, and rating response of their insulin use during the last month.”
BackgroundCelano, C. M., Freedman, M. E., Beale, E. E., Gomez-Bernal, F., & Huffman, J. C. (2018) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000883 · Cited by 41
Arnold, E. M., Swendeman, D. T., Harris, D., Fournier, J., Kozina, L., Abdalian, S., Rotheram‐Borus, M. J., & Adolescent Medicine Trials Network CARES Team (2018) · JMIR Research Protocols · doi:10.2196/10791 · Cited by 44
“Response categories range from “Very poor” (1) to “Excellent” (6) [72,73].”
Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
For the iPrEx Study Team, Amico, K. R., Mehrotra, M., Avelino‐Silva, V. I., McMahan, V., Veloso, V. G., Anderson, P. L., Guanira, J. V., & Grant, R. M. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1360-7 · Cited by 39
“Measurement strategies for assessing adherence to medications via self-report is a robust area of inquiry [19] and increasingly more general estimates of overall adherence are being used over discrete count approaches of doses taken and missed over a specified time period [20].”
Background
Metadata
- Authors
- Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., & Wilson, I. B.
- Affiliations
- Tufts Medical Center (US)
- Harvard University (US)
- Boston University (US)
- Corresponding author
- Wilson, Ira B.
- Venue
- AIDS and Behavior
- Published
- 2007-06-19
- Volume
- 12
- Issue
- 1
- Pages
- 86-94
- ISSN
- 1090-7165 (ISSN-L)
- 1573-3254
- OpenAlex
- W2054763716
- Cited by
- 361
- References
- 44
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 21 · 2022: 17 · 2021: 30 · 2020: 21 · 2019: 18 · 2018: 27 · 2017: 19 · 2016: 29 · 2015: 19 · 2014: 22 · 2013: 30 · 2012: 18
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- AIDS and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Center for AIDS Research, University of Washington
- Research England
- National Institute on Drug Abuse (R01DA015679)
- National Institute of Allergy and Infectious Diseases (P30-AI 42853, P30AI042853)
- National Center for Research Resources (M01 RR-00054, M01RR000054, K24RR020300)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Keywords
- HIV treatment adherence, antiretroviral therapy, self-report measures, recall period, overreporting, medication event monitoring system, measurement accuracy, rating scales
- MeSH terms
- Adult, Electronics, Female, Humans, Male, Patient Compliance, Surveys and Questionnaires, Mental Recall, Self Administration, Self Disclosure, Time Factors, HIV Infections, Treatment Outcome, Drug Monitoring, Cross-Over Studies, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.